Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Esther Artime's publication output changed over time?
ScholarIQpublication output · 2012–2023
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2023.
1
1
1
2
1
2
2
1
20122017201820192020202120222023
What are the most-cited papers on Esther Artime?
ScholarIQmost cited works
A comparison of organic and inorganic nitrates/nitrites
Sami A. Omar, Esther Artime, David J. Webb
S152998702. 2012105 Citations
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review
Manuel Barreiro‐de Acosta, Alberto Molero, Esther Artime, Silvia Díaz‐Cerezo, Luís Lizán, Héctor D. de Paz, María Dolores Martín‐Arranz
Advances in Therapy. 202375 CitationsOPEN ACCESS
A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies
Pareen Vora, Esther Artime, Montse Soriano‐Gabarró, Nawab Qizilbash, Vineet Singh, Alex Asiimwe
S140231191. 201847 CitationsOPEN ACCESS
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
Esther Artime, Irene Romera, Silvia Díaz‐Cerezo, Elías Delgado
Diabetes Therapy. 202141 CitationsOPEN ACCESS
Are risk minimization measures for approved drugs in Europe effective? A systematic review
Esther Artime, Nawab Qizilbash, Macarena Garrido‐Estepa, Pareen Vora, Montse Soriano‐Gabarró, Alex Asiimwe, Stuart Pocock
Expert Opinion on Drug Safety. 201936 Citations
Related on ScholarIQ
University of Greater Manchester
Institution
A comparison of organic and inorganic nitrates/nitrites
Paper
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review
Paper
A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies
Paper
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review
Paper
Are risk minimization measures for approved drugs in Europe effective? A systematic review
Paper